Search results for "Cardiovascular diseases"

showing 10 items of 2174 documents

Heat-shock protein 60 kDa and atherogenic dyslipidemia in patients with untreated mild periodontitis: a pilot study

2012

Identification of predictors of cardiovascular risk can help in the prevention of pathologic episodes and the management of patients at all stages of illness. Here, we investigated the relationships between serum levels of Hsp60 and dyslipidemia in patients with periodontitis by performing a cross-sectional study of 22 patients with mild periodontitis without any prior treatment for it (i.e., drug naive) and 22 healthy controls, matched for age and body mass index (BMI). All subjects were evaluated for periodontal status, gingival inflammation, and oral hygiene. Levels of circulating Hsp60, C-reactive protein (CRP), and plasma lipids were measured, and small, dense low-density lipoproteins …

AdultMalemedicine.medical_specialtyPeriodontal pathologyPilot ProjectsBiochemistryBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumansperiodontitisTriglyceridesDyslipidemiasPeriodontitisOriginal PaperbiologyCholesterolbusiness.industrydyslipidemiaC-reactive proteinAge FactorsMouth MucosaChaperonin 60Cell BiologyMiddle AgedHsp60medicine.diseaseLipidsHsp60; dyslipidemia; periodontitisLipoproteins LDLDrug-naïveC-Reactive ProteinCross-Sectional StudiesEndocrinologychemistryCardiovascular Diseasesbiology.proteinFemaleMetabolic syndromeLipoproteins HDLbusinessBody mass indexDyslipidemiamedicine.drugCell Stress and Chaperones
researchProduct

Behaviour of protein carbonyl groups in juvenile myocardial infarction.

2012

Acute myocardial infarction (AMI) is accompanied by oxidative stress, and protein oxidation is among the con- sequences of oxidative stress. We examined the plasma concentration of protein carbonyl groups (PC), a marker of protein oxidation, in a group of young subjects with AMI (45 men and 5 women; mean age 40.4 ± 4.8 yrs). We found a significant increase of PC (p < 0.001) in comparison with normal controls. No difference was observed between patients with AMI char- acterized by elevated ST segment and those without elevation of ST segment. There was no correlation between the ejection fraction and PC in the whole group nor in the subgroups of STEMI and non-STEMI patients. Subdividing the …

AdultMalemedicine.medical_specialtyPhysiologyProtein oxidationmedicine.disease_causeProtein CarbonylationRisk FactorsPhysiology (medical)Internal medicinemyocardial infarction; protein oxidationmedicineST segmentJuvenileHumansprotein oxidationcardiovascular diseasesMyocardial infarctionEjection fractionbusiness.industryMean ageHematologymedicine.diseaseSurgeryOxidative Stressmyocardial infarctionAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessProtein carbonylOxidative stress
researchProduct

Asymmetric Dimethylarginine and the Risk of Cardiovascular Events and Death in Patients With Coronary Artery Disease

2005

As a competitive inhibitor of endothelial nitric oxide synthase, asymmetric dimethylarginine (ADMA) has been related to atherosclerotic disease. Little is known about the prognostic impact of baseline ADMA determination. In a prospective cohort of 1908 patients with coronary artery disease, we assessed baseline serum concentration of ADMA in 1874 consecutive patients with coronary artery disease. One hundred fourteen individuals developed the primary end point of death from cardiovascular causes or nonfatal myocardial infarction during a mean follow-up of 2.6±1.2 years. Median concentrations of ADMA levels were higher among individuals who subsequently developed the primary end point than …

AdultMalemedicine.medical_specialtyPhysiologymedicine.drug_classCoronary DiseaseArginineCoronary artery diseasechemistry.chemical_compoundRisk FactorsInternal medicineNatriuretic Peptide BrainmedicineNatriuretic peptideHumansProspective StudiesMyocardial infarctionProspective cohort studyAgedbiologybusiness.industryHazard ratioC-reactive proteinMiddle Agedmedicine.diseaseConfidence intervalC-Reactive ProteinchemistryCardiovascular DiseasesCreatininebiology.proteinCardiologyFemaleCardiology and Cardiovascular MedicineAsymmetric dimethylargininebusinessBiomarkersCirculation Research
researchProduct

Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: Data from the German CVSS-study.

2018

Aims: The cardiac and vascular late sequelae in long-term survivors of childhood cancer (CVSS)-study aimed to quantify the prevalence of cardiovascular risk factors (CVRF) and cardiovascular disease (CVD) in German childhood cancer survivors (CCS). Methods and results: In the CVSS-study (NCT02181049), 1002 CCS (age range 23-48 years) diagnosed with neoplasia prior to 15 years of age between 1980 and 1990 prospectively underwent a systematic, standardized clinical and laboratory cardiovascular screening, identical to the population-based Gutenberg Health Study (GHS) cohort. For 951 individuals, prevalences of CVRF and CVD were primarily compared to the GHS sample and to two further German po…

AdultMalemedicine.medical_specialtyPopulationComorbidity030204 cardiovascular system & hematologyYoung Adult03 medical and health sciences0302 clinical medicineCancer SurvivorsRisk FactorsGermanyDiabetes mellitusInternal medicineDiabetes MellitusPrevalenceHumansMedicineObesityAge of OnsetSex DistributionYoung adulteducationeducation.field_of_studybusiness.industrySmokingMiddle Agedmedicine.diseaseComorbidityConfidence intervalCardiotoxicity ; Long-term Survivors ; Late Sequelae ; Cardiovascular Morbidity ; Cardio-oncologyCardiovascular Diseases030220 oncology & carcinogenesisRelative riskCohortFemaleAge of onsetCardiology and Cardiovascular Medicinebusiness
researchProduct

LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.

2018

Abstract Background The association of low-density lipoprotein (LDL) particle composition with cardiovascular risk has not been explored before. The aim was to evaluate the relationship between baseline LDL particle size and composition (proportions of large, medium and small LDL particles over their sum expressed as small-LDL %, medium-LDL % and large-LDL %) and incident cardiovascular disease in a population-based study. Methods Direct measurement of LDL particles was performed using a two-dimensional NMR-technique (Liposcale®). LDL cholesterol was assessed using both standard photometrical methods and the Liposcale® technique in a representative sample of 1162 adult men and women from Sp…

AdultMalemedicine.medical_specialtyPopulationCoronary DiseaseDisease030204 cardiovascular system & hematologyRisk AssessmentCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansMetabolomicsProspective Studies030212 general & internal medicineParticle SizeProspective cohort studyeducationStrokeAgedAged 80 and overeducation.field_of_studybusiness.industryHazard ratioMiddle Agedmedicine.diseaseCor MalaltiesLipoproteins LDLStrokeCardiovascular DiseasesSpainCardiologyFemaleComposition (visual arts)lipids (amino acids peptides and proteins)Geometric meanCardiology and Cardiovascular MedicinebusinessLipoprotein
researchProduct

Prevalence of metabolic syndrome and cardiovascular disease in a hypertriglyceridemic population

2011

BACKGROUND: We aim to study the prevalence of metabolic syndrome (MS), hypertension and diabetes, and their relationship to cardiovascular disease in subjects with hypertriglyceridemia. METHODS: This is an observational cross-sectional study, uncontrolled and multicentre study. Selected subjects were patients with hypertriglyceridemia (triglycerides, TG, ≥ 200 mg/dl) visited in the Lipid Units of the Spanish Arteriosclerosis Society who met the inclusion criteria. Prevalence of MS (ATPIII and IDF criteria, MS-ATPIII or MS-IDF), hypertension and diabetes were studied. The presence of cardiovascular disease (CVD) was also determined. RESULTS: The results showed that individuals referred for h…

AdultMalemedicine.medical_specialtyPopulationDiseaseDiabetes ComplicationsRisk FactorsInternal medicineDiabetes mellitusDiabetes MellitusPrevalenceInternal MedicinemedicineHumansIn patienteducationAgedHypertriglyceridemiaMetabolic Syndromeeducation.field_of_studybusiness.industryHypertriglyceridemianutritional and metabolic diseasesArteriosclerosisMiddle Agedmedicine.diseaseCross-Sectional StudiesCardiovascular DiseasesSpainHypertensionCardiologyFemaleObservational studyMetabolic syndromebusinessEuropean Journal of Internal Medicine
researchProduct

Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.

2012

Abstract Aims and background Midregional proadrenomedullin (MR-proADM) is a protein, which exerts various effects on the cardiovascular system. Recent studies underscored its prognostic implications in patients with acute dyspnea and cardiovascular diseases. Therefore, we aimed to determine the distribution of MR-proADM in the general population and to reveal potential associations of MR-proADM with cardiovascular risk factors and measures of subclinical cardiovascular disease. Methods and results MR-proADM plasma concentrations were determined in individuals of the population-based cohort of the Gutenberg Health Study ( N  = 5000) using a commercially available fluoroimmunoassay. Individua…

AdultMalemedicine.medical_specialtyPopulationFluoroimmunoassayRisk AssessmentCoronary artery diseaseAdrenomedullinSex FactorsPredictive Value of TestsRisk FactorsInternal medicineGermanymedicinePrevalenceHumansMyocardial infarctionProspective StudiesProtein PrecursorseducationSubclinical infectionAgededucation.field_of_studybusiness.industryAge FactorsMiddle Agedmedicine.diseasePrognosisPeptide FragmentsUp-RegulationCross-Sectional StudiesPhenotypeIntima-media thicknessCardiovascular DiseasesEchocardiographyHeart failureAsymptomatic DiseasesCardiologyLinear ModelsPopulation studyFemaleCardiology and Cardiovascular MedicinebusinessHeart failure with preserved ejection fractionBiomarkersAtherosclerosis
researchProduct

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertensio…

2010

Abstract Background The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study. Methods/Design A cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System…

AdultMalemedicine.medical_specialtyPopulationRisk AssessmentCohort StudiesStudy ProtocolEnvironmental healthEpidemiologyDiabetes MellitusmedicineHumansProspective StudieseducationAgedDyslipidemiasAged 80 and overeducation.field_of_studyMediterranean Regionbusiness.industrylcsh:Public aspects of medicinePublic healthPublic Health Environmental and Occupational Healthlcsh:RA1-1270Middle Agedmedicine.diseaseCardiovascular DiseasesHypertensionCohortPhysical therapyFemaleBiostatisticsRisk assessmentbusinessDyslipidemiaCohort studyBMC Public Health
researchProduct

Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics

2017

BACKGROUND People with schizophrenia and other severe mental disorders have an increased mortality mainly attributed to natural causes, specifically cardiovascular disease and cancer. The metabolic syndrome and the Framingham Risk Score are epidemiologic tools related to long-term cardiovascular disease risk and they are increased in people with severe mental disorders. This increase has been attributed both to the disorder itself and to the use of antipsychotic drugs. OBJECTIVE To quantify the cardiovascular risk in a group of people treated with long-acting injectable antipsychotics. METHODS This is a cross-sectional study developed in an outpatient mental health clinic in which the preva…

AdultMalemedicine.medical_specialtyPsychosisHealth StatusEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHealth BehaviorDiseasePharmacologyRisk AssessmentSeverity of Illness IndexInjectionsHabitsYoung Adult03 medical and health sciences0302 clinical medicineCost of IllnessRisk FactorsInternal medicinePrevalencemedicineHumansImmunology and AllergyAntipsychoticLife StyleAgedMetabolic SyndromeFramingham Risk Scorebusiness.industryMental DisordersMiddle Agedmedicine.diseaseMental healthObesity030227 psychiatryCross-Sectional StudiesCardiovascular DiseasesSpainSchizophreniaDelayed-Action PreparationsFemaleMetabolic syndromebusiness030217 neurology & neurosurgeryAntipsychotic AgentsEndocrine, Metabolic &amp; Immune Disorders - Drug Targets
researchProduct

Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

2016

Aims.In recent years several warnings have been issued by regulatory authorities on the risk of electrocardiogram abnormalities in individuals exposed to psychotropic drugs. As a consequence of these warnings, monitoring of the QT interval corrected for heart rate (QTc) has become increasingly common. This study was conducted to measure the frequency of QTc prolongation in unselected psychiatric patients, and to document the associated factors using a cross-sectional approach.Method.The study was carried out in 35 Italian psychiatric services that are part of the STAR (Servizi Territoriali Associati per la Ricerca) Network, a research group established to produce scientific knowledge by col…

AdultMalemedicine.medical_specialtyPsychotropic drugsEpidemiologymedicine.medical_treatmentLong QT syndromeAntidepressantDrug overdoseAdverse effectQT intervalAntipsychotic03 medical and health sciencesElectrocardiography0302 clinical medicineRisk FactorsPsychotropic drugmedicinePrevalenceHumanscardiovascular diseasesAntipsychoticAdverse effectPsychiatrySettore MED/25 - PsichiatriaPolypharmacybusiness.industryEnvironmental and Occupational HealthPublic Health Environmental and Occupational HealthAdverse effect; Antidepressant; Antipsychotic; Psychotropic drugs; Epidemiology; Public Health; Environmental and Occupational Health; Psychiatry and Mental HealthOriginal Articlesmedicine.diseaseAdverse effect; Antidepressant; Antipsychotic; Psychotropic drugs; Epidemiology; Public Health Environmental and Occupational Health; Psychiatry and Mental Health030227 psychiatrySubstance abuseLong QT SyndromeCross-Sectional StudiesItalyPsychiatry and Mental HealthPolypharmacyAripiprazoleFemalePublic HealthbusinessAntidepressant; adverse effect; antipsychotic; psychotropic drugsAdverse effect; Antidepressant; Antipsychotic; Psychotropic drugs; Adult; Antipsychotic Agents; Cross-Sectional Studies; Electrocardiography; Female; Humans; Italy; Long QT Syndrome; Male; Prevalence; Risk Factors; Polypharmacy; Epidemiology; Public Health Environmental and Occupational Health; Psychiatry and Mental Health030217 neurology & neurosurgerymedicine.drugAntipsychotic AgentsEpidemiology and psychiatric sciences
researchProduct